Oracle Health, the nation’s second-largest EHR vendor by market share, had a busy December, with health system project and AI customer expansions. Here are 11 times Becker’s reported on the company in ...

Oracle’s earnings report last week didn’t do much to soothe concerns about how the company will fund its artificial-intelligence investments. In fact, investor sentiment has taken a turn for the worse ...

Oracle (ORCL) is well-positioned to benefit from AI adoption by leveraging its integrated infrastructure, database, and ...

Oracle’s results are incredibly impressive. Oracle has a clear runway for future growth. Microsoft has a better risk/reward profile than Oracle. Investors are concerned that Oracle's spending is too ...

After five decades of selling enterprise software, Oracle ORCL0.25%increase; green up pointing triangle has amassed a lot of very large customers. But never before has the company’s fate hinged so ...

Shares in the technology company are down as investors grow anxious that its bet on artificial intelligence, and OpenAI in particular, may not pay off. By Andrew Ross Sorkin Bernhard Warner Sarah ...

Cerner was dismissed as a messy integration. Now it looks more like an AI jackpot. Oracle sits inside hospitals, insurers, clinical workflows and electronic health records — the parts of U.S. health ...

A new update was available for iPhone users back in September; Apple’s iOS 26, which introduced the Liquid Glass design and new features thanks to its artificial intelligence system. Now, iPhone users ...

One analyst expects the company will provide an update on financing needs that could show they're 'less demanding' than what Wall Street fears Oracle reports earnings on Dec. 10. Many ...

The bears have won out on Oracle’s stock lately, but one analyst thinks the powerful recent selloff just means more opportunity for buyers. Oracle ORCL has become a battleground stock in the months ...

Oracle will sail through the debt-backlog storm to claim its place in the AI oligopoly. I am targeting a 50% 12-month return. Short-sellers and media skeptics play a role, but optimists prevail in the ...

DA Davidson analyst Gil Luria just cut Oracle's price target by one-third. Luria worries that Oracle's OpenAI contract may not be as good as it seems. I warned that Oracle stock cost too much at $328 ...